Officer sold
Incyte's & Chief Scientific Officer sold $531K of Incyte shares. Nobody planned it ahead of time.
Loading…
Traded Nov 10, 2025 · Filed Nov 12, 2025
A board member of Incyte sold $19.8M of Incyte shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$19,773,750
Shares × reported transaction price
13 days after results of Oct 28, 2025, 92 days before results of Feb 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $105.98 on Nov 10, 2025, at its 52-week high, after a 26% rise over the previous 30 trading days
52-week range $55.17 (Apr 10, 2025) to $105.98 (Nov 7, 2025), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $83.89 on Sep 29, 2025. Describes the past only, not a forecast
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.5% | -2.9% | -0.6% |
| 30 days | -6.4% | +1.3% | -7.7% |
| 90 days | -6.2% | +3.0% | -9.2% |
| 180 days | -6.0% | +9.8% | -15.8% |
Past results only. Not a forecast.
Incyte's & Chief Scientific Officer sold $531K of Incyte shares. Nobody planned it ahead of time.
Routine share withholding; mechanical by default.